Xtant Medical Holdings (XTNT) Short-Term Debt repayments (2017 - 2025)

Xtant Medical Holdings (XTNT) has 6 years of Short-Term Debt repayments data on file, last reported at $26.5 million in Q3 2025.

• Quarterly Short-Term Debt repayments rose 2.71% year-over-year to $26.5 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $105.5 million (up 5.16% YoY) and the FY2024 annual result came in at $105.1 million, up 36.59% from the prior year.
• Short-Term Debt repayments improved to $26.5 million in Q3 2025 per XTNT's latest filing, from $25.9 million in the prior quarter.
• Across five years, Short-Term Debt repayments topped out at $27.5 million in Q2 2024 and bottomed at $12.3 million in Q1 2022.
• The 5-year median for Short-Term Debt repayments is $20.1 million (2023), against an average of $20.1 million.
• The widest annual swing landed in 2022, when Short-Term Debt repayments retreated 6.36%; it then soared 55.04% in 2024.
• Tracing XTNT's Short-Term Debt repayments over 5 years: stood at $13.5 million in 2021, then grew by 10.6% to $14.9 million in 2022, then surged by 49.44% to $22.3 million in 2023, then gained by 21.75% to $27.1 million in 2024, then dropped by 2.33% to $26.5 million in 2025.
• Per Business Quant, the three latest XTNT Short-Term Debt repayments figures stand at $26.5 million (Q3 2025), $25.9 million (Q2 2025), and $26.0 million (Q1 2025).

Peer Comparison